|
|
||||||||
J Thorac Cardiovasc Surg 1997;114:143-144
© 1997 Mosby, Inc.
BRIEF COMMUNICATIONS |
Madison, Wis.
Received for publication Jan. 14, 1997 accepted for publication Jan. 23, 1997. Address for reprints: M. Salik Jahania, MD, Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky Medical Center, Room MN 264, 800 Rose St., Lexington, KY 40536-0084.
The treatment of patients with end-stage heart disease includes administration of digoxin, diuretics, and angiotensin-converting enzyme inhibitors. Persistence of symptoms despite maximal medical therapy may lead to initiation of intravenous inotropic support and ultimately heart transplantation. Because up to 30% of patients waiting for a heart transplant may die before a suitable donor organ becomes available, many individuals are considered candidates for temporary mechanical circulatory support with a left ventricular assist device (LVAD) as a bridge to transplantation.
1 One such device, the Thermo Cardiosystems, Inc., HeartMate Implantable Pneumatic (TCI IP) LVAD (Woburn, Mass.), has been used successfully in North America and Europe. Although this device has been remarkably free of mechanical failure,
2 we report a unique complication that could be catastrophic if not diagnosed and treated immediately.
Clinical summary.
A 50-year-old man with idiopathic cardiomyopathy experienced shortness of breath and increasing fatigue for 2 years. With increasing dyspnea on exertion and tachycardia, he was admitted to a local hospital, given inotropic support, administered diuretics, and transferred to the University of Wisconsin Hospital and Clinics for evaluation and possible cardiac transplantation. Cardiac catheterization 3 months earlier had revealed minimal coronary artery disease and severe biventricular hypokinesis with an ejection fraction of 0.12. On admission, blood pressure was 92/60 mm Hg, heart rate was 104 beats/min, and respiratory rate was 28 breaths/min. Right heart catheterization revealed a cardiac index of 1.6 L/min per square meter and a pulmonary capillary wedge pressure of 30 mm Hg. Despite infusions of dobutamine (7.5 µg/kg per minute), dopamine (5 µg/kg per minute), and milrinone (0.5 µg/kg per minute), the cardiac index increased only marginally (1.9 L/min per square meter). An intraaortic balloon pump was inserted and the patient was taken on an emergency basis to the operating room for implantation of a TCI IP LVAD.
Three weeks later he was able to exercise up to 8 METS without difficulty. On return from an exercise session, the HeartMate console panel showed low flow and the alarm sounded. The interconnect cable and console were changed, but that had no effect on the console panel indicators. Failure of the device was suspected and the patient was given 10,000 IU of heparin to prevent stagnant blood from clotting inside the pump housing. He was immediately administered infusions of dobutamine (10 µg/kg per minute) and milrinone (0.5 µg/kg per minute) and was transferred to the intensive care unit. Physical examination revealed a blood pressure of 100/64 mm Hg and a heart rate of 100 beats/min. The usual audible pumping sound was absent. On auscultation of the abdomen a gurgling sound was heard in the left upper quadrant. Chest and abdominal roentgenograms revealed free air under the diaphragm and presumptive evidence of disruption of the pneumatic drive line from the pump housing (Fig. 1). Fluoroscopic examination showed the pusher plate inside the pump housing to be immobile.
|
|
Discussion.
With increased use of the HeartMate IP LVAD as a bridge to heart transplantation, it is possible that device malfunction will be encountered more frequently. This is the first report of separation of the pneumatic drive line from the pump housing. The manufacturer of the device has now modified the connection between the pneumatic drive line and the titanium pump housing. Ideally this will prevent further such complications. It is doubtful that the separation was related to exercise, because the pneumatic drive line was secure. Our exercise protocol for patients having a HeartMate LVAD remains unchanged. Although this type of device malfunction could be life threatening, rapid diagnosis and appropriate management can yield a satisfactory result.
References
This article has been cited by other articles:
![]() |
P. M. McCarthy, N. O. Smedira, R. L. Vargo, M. Goormastic, R. E. Hobbs, R. C. Starling, and J. B. Young One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 904 - 912. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |